Roy El Darzi

Back to Journals » Journal of Hepatocellular Carcinoma » Volume 13 Authors El Darzi R , Ashy C , Khrayzat A, Chahine S, Tawil A, Temraz S Received 3 February 2026 Accepted for publication 18 April 2026 Published 6 May 2026 Volume 2026:13 597439 DOI https://doi.org/10.2147/JHC.S597439 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Ali Hosni Roy El Darzi,1,* Christopher Ashy,1,* Ali Khrayzat,2 Sally...

Abstract The treatment landscape of non-small-cell lung cancer (NSCLC) is evolving rapidly, driven by advances in the development of targeted agents and immunotherapies. Despite this progress, some patients have suboptimal responses to treatment, highlighting the need for new therapeutic strategies. In the past decade, the important role of the tumour microenvironment (TME) in NSCLC progression, metastatic dissemination and response to treatment has become increasingly evident.